Amgen Inc.

🇺🇸NASDAQ Global Select
Back to all articles
Amgen Inc. stock analysis AMGN overview
Slightly Bearish -10

Are Options Traders Betting on a Big Move in Amgen Stock?

📊 Amgen stock options with a May 15, 2026 $200 strike price are exhibiting the highest implied volatility among all equity options today.

⚙️ High implied volatility typically signals that investors anticipate significant future price movement or an upcoming catalyst event.

📉 Analyst sentiment is currently mixed, with five analysts lowering earnings estimates while only one raised them for the current quarter.

🔄 These recent analyst adjustments have lowered Zacks Consensus Estimate per share from $5.81 to $5.64.

🔬 Amgen holds a Zacks Rank #3 (Hold) rating and ranks in the bottom 40% of its Medical-Biomedical and Genetics industry sector.

💰 Options traders may be targeting this high implied volatility to sell premium and capture time decay if the stock does not move significantly.

📈 The article concludes by promoting Zacks Investment Research's independent tools and rankings rather than providing a definitive price target for Amgen.

Bullish Signals
  • Options traders are pricing in significant movement for Amgen stock, as evidenced by the May 15, 2026 $200 Call having some of the highest implied volatility among all equity options today.
  • Since 1988, Zacks Investment Research's list of elite stocks has beaten the market more than 2X over with an average gain of +23.9% per year, suggesting potential for early price pops in selected tickers.
  • Zacks Investment Research offers tools like the Price Response Indicator and Earnings ESP to help investors succeed, built on a history of averaging +23.89% annual returns since 1988.
Risk Factors
  • Amgen Inc. (AMGN) currently holds a Zacks Rank #3, indicating a 'Hold' rating, and ranks in the bottom 40% of its medical industry peers.
  • Over the last 30 days, five analysts have dropped their earnings estimates for the current quarter, while only one increased them.
  • This negative sentiment among analysts has caused the Zacks Consensus Estimate for the current quarter to decline from $5.81 per share to $5.64 per share.
  • High implied volatility in the May 15, 2026 $200 Call options suggests a market expectation of a large move that could result in a significant sell-off rather than a rally.
Full Analysis
Amgen Inc. (AMGN) is drawing attention from options traders due to significant implied volatility observed on the May 15, 2026, $200 call option, which ranks among the highest for equity options today. High implied volatility indicates that the market expects substantial price movement in the near future, often linked to upcoming events that could trigger a rally or sell-off, though traders may also be pricing this volatility to sell premium and capture time decay by hoping the stock does not move as anticipated. Fundamentally, the company currently holds a Zacks Rank of #3, categorized as "Hold" within the Medical - Biomedical and Genetics industry, placing it in the bottom 40% of its sector ranking according to the analysis provided. Analyst sentiment appears mixed over the last month, with one analyst increasing earnings estimates for the current quarter while five others have lowered them, resulting in a revised Zacks Consensus Estimate of $5.64 per share compared to the previous figure of $5.81. While options traders are clearly positioning for a potential big move, the fundamental picture suggests caution, as the consensus has adjusted downward and the company faces significant competition in its high-value market segments. The article highlights that this volatility could signal an active trade developing, where sellers may benefit from the uncertainty regardless of the direction of the underlying stock price movement at expiration. Investors are advised to weigh these options market signals against the current fundamental standing and recent analyst revisions before making trading decisions on the ticker.